Johnson & Johnson Innovative Medicine
About the organisation
Johnson & Johnson Innovative Medicine (formerly known as Janssen Pharmaceuticals) is the pharmaceutical division of the American corporation Johnson & Johnson, specializing in the development and production of revolutionary medicines. The company focuses on creating treatments for the most complex diseases, transforming the future of healthcare.-CAR-T Research https://www.jnj.com/innovativemedicine/
What the listing means
Johnson & Johnson Innovative Medicine appeared on the spacebears leak site on 04 May 2026. Groups publish a victim once negotiations stall or as pressure during them, so a listing usually means data was already exfiltrated — the attack itself is dated 26 April 2026, 8 days before the listing. This group has published 7 claims in the last 30 days and remains active.
Recommended actions
- Treat any unsolicited message referencing Johnson & Johnson Innovative Medicine as suspicious — leaked data gets weaponised for phishing within days.
- If you hold an account on www.jnj.com/innovativemedicine, change that password now, update it anywhere you reused it, and enable two-factor authentication.
- Other Healthcare organisations should review this group's known TTPs and validate detection coverage against them.
- Watch for follow-on extortion: stolen data is often re-leaked or resold after the initial listing.
- A leak-site listing is a claim made by the attacker, not a confirmed breach — check the organisation's own disclosures before acting on it.
Leak-site evidence
Listing URL https://www.ransomware.live/id/Sm9obnNvbiAmIEpvaG5zb24gSW5ub3ZhdGl2ZSBNZWRpY2luZUBzcGFjZWJ...
Show leak-site screenshot
Captured from the group's extortion site. It may contain the victim's data or the attacker's messaging.
